Logotype for Creades

Creades (CRED) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Creades

Q2 2025 earnings summary

11 Jul, 2025

Executive summary

  • Net asset value return for H1 2025 was +8%, outperforming OMXSGI's +2% in the same period.

  • Three major transactions: acquisition agreement for 10.1% of Silex Microsystems, sale of 64% of Apotea, and agreement to sell Stabelo.

  • Portfolio companies showed mixed performance, with strong gains in Avanza and Inet, but declines in StickerApp, Klarna, and Instabee.

  • Cash position at period end was SEK 720 mn, with additional SEK 347 mn in uninvested managed funds.

Financial highlights

  • Net profit for H1 2025 was SEK 780 mn, up from SEK 732 mn year-over-year.

  • Earnings per share for the period were SEK 5.75 (vs. SEK 5.39 last year); Q2 EPS was SEK 4.43 (vs. SEK 5.68 last year).

  • Net asset value per share rose to SEK 80 from SEK 75 at year-end 2024.

  • Dividend of SEK 1.60 per share (SEK 217 mn total) to be paid in four installments.

  • Solid cash flow from operations and investment activities, with period-end liquidity of SEK 720 mn.

Outlook and guidance

  • Management targets annual net asset value return above 7.5% and to outperform OMXSGI.

  • Silex Microsystems acquisition expected to close in Q3 2025, with Creades taking an active ownership role.

  • Sale of Stabelo to Swedbank expected to complete in Q4 2025, with potential earn-out through 2028.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Creades